| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $21.04M | - | |
| CEO | 1.74M | $11.09M | -41,666 | |
| Other | 409.9K | $2.61M | - | |
| CFO | 409.1K | $2.61M | - | |
| Other | 339.5K | $2.16M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2021 | Rosenbaum David P.59 | Chief Development Officer | Sell | 5,000 | $8.00 | $40,000.00 | -3.0% | +7.9% | -85.7% | |
| Apr 6, 2021 | Blanks Robert | See Remarks | Sell | 5,163 | $8.00 | $41,304.00 | -2.3% | +7.9% | -85.7% | |
| Feb 22, 2021 | Blanks Robert | See Remarks | Sell | 593 | $6.88 | $4,081.32 | -0.5% | +0.4% | -90.1% | |
| Feb 22, 2021 | Jacobs Jeffrey W66 | Chief Scientific Officer | Sell | 702 | $6.88 | $4,831.52 | -0.6% | +0.4% | -90.1% | |
| Feb 22, 2021 | Rodriguez Susan45 | Chief Commercial Officer | Sell | 611 | $6.88 | $4,205.21 | -1.3% | +0.4% | -90.1% | |
| Feb 22, 2021 | Raab Michael56 | President &CEO | Sell | 2,534 | $6.88 | $17,440.26 | -1.2% | +0.4% | -90.1% | |
| Feb 22, 2021 | Rosenbaum David P.59 | Chief Development Officer | Sell | 805 | $6.88 | $5,540.41 | -0.4% | +0.4% | -90.1% | |
| Feb 22, 2021 | Renz Justin A54 | Chief Financial Officer | Sell | 608 | $6.88 | $4,184.56 | -1.5% | +0.4% | -90.1% | |
| Feb 22, 2021 | Grammer Elizabeth A58 | See Remarks | Sell | 504 | $6.88 | $3,468.78 | -0.5% | +0.4% | -90.1% | |
| Dec 21, 2020 | Jacobs Jeffrey W66 | Chief Scientific Officer | Sell | 3,949 | $6.88 | $27,153.32 | -4.1% | - | - |